A first-in-class gene-regulating therapy cut seizures by up to 91% in children with Dravet syndrome in extension studies, raising hopes for a disease-modifying treatment.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/first-class-therapy-dravet-syndrome-shows-promising-early-2026a1000706?src=rss
Author :
Publish date : 2026-03-06 17:11:00
Copyright for syndicated content belongs to the linked Source.